WELLINGTON, Aug 30 (Reuters) – New Zealand reported its first recorded death linked to U.S. drugmaker Pfizer’s COVID-19 vaccine, the health ministry said on Monday, after a woman suffered a rare side effect leading to inflammation of her heart muscle.
The news of the death comes as the country battles an outbreak of the Delta variant after nearly six months of being virus free. It followed a review by an independent panel monitoring the safety of the vaccines.
“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine,” the ministry said in a statement, without giving the woman’s age.
finance.yahoo.com/news/1-zealand-reports-first-death-023101292.html